GO:1990629 phospholamban complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990629 (phospholamban complex) is a cellular_component term describing a homopentamer of PLN in the sarcoplasmic reticulum membrane of cardiomyocytes.
• The phospholamban complex regulates intracellular calcium and is a main determinant of cardiac muscle contraction and relaxation.
• The cardiomyopathy variant PLN R14del increases pentamer stability and blunts dynamic calcium regulation.
• Age-related penetrance of the PLN p.Arg14del variant is a key clinical feature of PLN-related cardiomyopathy.
• PLN interacts with SERCA1 and small ankyrin 1 to form a three-way complex, linking calcium handling to membrane scaffolding.
• Phospholamban phosphorylation is dynamically regulated, including by macrophage migration inhibitory factor in cardiac muscle.
Description
The phospholamban complex (GO:1990629) is a protein complex found as a homopentamer of the phospholamban (PLN) protein in the sarcoplasmic reticulum (SR) membrane of cardiomyocytes. Cardiac PLN is a main determinant of muscle contraction and relaxation by regulating intracellular calcium levels. Because PLN sits at the interface of calcium cycling and contractile performance, it is a central node for understanding inherited cardiomyopathies and for developing targeted experimental models. The complex is not a static structure; its assembly state and phosphorylation status tune SERCA activity and calcium reuptake, making it a dynamic regulator of cardiac physiology. Researchers studying heart failure, arrhythmia, and calcium-handling disease therefore need reliable tools to interrogate PLN complex composition, stability, and regulation.
phospholamban complex At A Glance
| GO ID | GO:1990629 |
|---|---|
| GO term | phospholamban complex |
| Ontology | cellular_component |
| Synonym | cardiac phospholamban complex; cardiac PLB complex; cardiac PLN complex |
| Major function | Regulates intracellular calcium levels in cardiomyocytes, influencing muscle contraction and relaxation |
| Location | Sarcoplasmic reticulum (SR) membrane of cardiomyocytes |
| Composition | Homopentamer of the phospholamban (PLN) protein |
| Disease relevance | PLN p.Arg14del is associated with cardiomyopathy with age-related penetrance |
| Interacting partners | SERCA1 and small ankyrin 1 can form a three-way complex with PLN |
What Is GO:1990629?
GO:1990629, phospholamban complex, is defined as a protein complex found as a homopentamer of the phospholamban (PLN) protein in the sarcoplasmic reticulum (SR) membrane of cardiomyocytes. Cardiac PLN is a main determinant of muscle contraction and relaxation, by regulating intracellular calcium levels. In practical terms, it is the pentameric assembly of PLN that resides in the SR membrane and participates in calcium handling in heart muscle cells.
Why Is phospholamban complex Important in Cell Biology?
The phospholamban complex is important because it directly controls calcium reuptake into the sarcoplasmic reticulum, thereby setting the pace of cardiac relaxation and the strength of subsequent contraction. Dysregulation of PLN, including the cardiomyopathy-associated R14del variant, alters pentamer stability and blunts dynamic calcium regulation, which can lead to dilated cardiomyopathy and malignant ventricular arrhythmias. Because the complex is a convergence point for phosphorylation-dependent regulation, it is also a target for understanding how signaling pathways modify cardiac contractility. For researchers, GO:1990629 provides a precise annotation for experimental models that probe SR calcium handling, protein-protein interactions, and inherited heart disease mechanisms.
• Controls intracellular calcium levels in cardiomyocytes, a core determinant of contraction and relaxation.
• The PLN R14del variant increases pentamer stability and blunts dynamic calcium regulation.
• PLN p.Arg14del cardiomyopathy shows age-related penetrance, relevant to clinical risk stratification.
• Epicardial adipose tissue is linked to malignant ventricular arrhythmias in PLN p.(Arg14del) variant carriers.
• PLN interacts with SERCA1 and small ankyrin 1, forming a three-way complex that links calcium handling to membrane structure.
• Phospholamban phosphorylation is dynamically regulated in cardiac muscle, including by macrophage migration inhibitory factor.
• The complex is a key node in heart failure research and contractility regulation.
• Thyroid hormone signaling influences cardiac hypertrophy, a context in which PLN regulation is relevant.
• PLN complex biology informs experimental models for inherited cardiomyopathy and arrhythmia.
• GO:1990629 enables precise annotation of SR membrane protein assemblies in cardiac research.
What Happens During phospholamban complex?
Assembly of the PLN homopentamer
In simple terms: Five PLN proteins come together to form a pentamer in the heart cell membrane.
The phospholamban complex is a homopentamer of the PLN protein located in the sarcoplasmic reticulum membrane of cardiomyocytes. This assembly state is functionally important because the cardiomyopathy variant R14del increases phospholamban pentamer stability, which blunts dynamic regulation of calcium.
Calcium regulation and contractility
In simple terms: The PLN complex helps control how much calcium is stored and released, which sets how strongly the heart contracts.
Cardiac PLN is a main determinant of muscle contraction and relaxation by regulating intracellular calcium levels. Because the phospholamban complex resides in the SR membrane, its regulation directly influences calcium reuptake and cardiac contractility.
Phosphorylation-dependent regulation
In simple terms: Adding phosphate groups to PLN changes its behavior and tunes calcium handling.
Phospholamban phosphorylation is dynamically regulated in cardiac muscle, and macrophage migration inhibitory factor can induce phospholamban phosphorylation. This phosphorylation-dependent control is a key mechanism by which the complex responds to signaling inputs.
Interaction with SERCA and ankyrin
In simple terms: PLN binds to other proteins like SERCA1 and small ankyrin 1, forming a larger functional assembly.
Small ankyrin 1 interacts with phospholamban and forms a three-way complex with SERCA1. This interaction links the phospholamban complex to calcium pump regulation and membrane scaffolding.
Disease-associated dysfunction
In simple terms: Mutations in PLN can make the complex too stable or poorly regulated, leading to heart disease.
The dilated cardiomyopathy variant R14del increases phospholamban pentamer stability, blunting dynamic regulation of calcium. Age-related penetrance of the phospholamban p.Arg14del cardiomyopathy has been described, and epicardial adipose tissue has been linked to malignant ventricular arrhythmias in p.(Arg14del) variant carriers.
Key Genes Involved in GO:1990629 phospholamban complex
The phospholamban complex is centered on PLN, but its function and regulation involve a network of interacting proteins and signaling genes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLN | Forms the homopentameric phospholamban complex in the SR membrane | Core component; R14del variant increases pentamer stability and blunts calcium regulation |
| SERCA1 | Calcium pump that forms a three-way complex with PLN and small ankyrin 1 | Links phospholamban complex to calcium reuptake machinery |
| ANK1 | Small ankyrin 1 interacts with phospholamban and SERCA1 | Membrane scaffolding partner of the phospholamban complex |
| PRKACA | Catalytic subunit of cAMP-dependent protein kinase, relevant to cardiac contractility regulation | Signaling kinase that can influence PLN phosphorylation and contractility |
| PRKAR1A | RIα subunit of cAMP-dependent protein kinase regulates cardiac contractility and heart failure development | Regulatory subunit linked to contractility and heart failure |
| MIF | Macrophage migration inhibitory factor induces phospholamban phosphorylation in cardiac muscle | Extracellular signal that modifies PLN phosphorylation |
| THRA | Thyroid hormone receptor alpha, involved in cardiac hypertrophy and thyroid hormone signaling | Context for hypertrophy-related regulation of cardiac genes |
| THRB | Thyroid hormone receptor beta, involved in cardiac hypertrophy and thyroid hormone signaling | Context for hypertrophy-related regulation of cardiac genes |
| MYH7 | Sarcomeric myosin heavy chain, relevant to cardiomyopathy and sarcomere disassembly | Contractile apparatus context for PLN-related calcium handling |
| ADD1 | Adducin regulates sarcomere disassembly during cardiomyocyte mitosis | Cytoskeletal regulation relevant to cardiomyocyte biology |
| TNNT2 | Cardiac troponin T, a sarcomeric protein in contractile regulation | Contractile machinery context for calcium handling |
| ACTN2 | Alpha-actinin-2, a sarcomeric structural protein | Sarcomere organization context |
| MYBPC3 | Cardiac myosin binding protein C, sarcomeric regulator | Cardiomyopathy-related sarcomeric gene |
| TTN | Titin, a giant sarcomeric protein | Sarcomere structure and cardiomyopathy relevance |
| RYR2 | Ryanodine receptor 2, calcium release channel in cardiomyocytes | Calcium handling partner in SR membrane |
| ATP2A2 | SERCA2 calcium pump in cardiac SR | Calcium reuptake machinery functionally linked to PLN |
| CALM1 | Calmodulin, calcium sensor in cardiac signaling | Calcium signaling context for PLN regulation |
| NPPA | Atrial natriuretic peptide, marker of cardiac hypertrophy | Readout of hypertrophic signaling |
How Is phospholamban complex Regulated?
The phospholamban complex is regulated by phosphorylation events that alter its interaction with calcium-handling machinery. Macrophage migration inhibitory factor induces phospholamban phosphorylation in cardiac muscle, providing one signaling route for dynamic control. cAMP-dependent protein kinase signaling, including the RIα subunit, regulates cardiac contractility and heart failure development, which places PLN phosphorylation within a broader kinase-controlled network. Thyroid hormone signaling influences cardiac hypertrophy, a context in which cardiac gene regulation, including PLN-related calcium handling, is relevant. In addition, the R14del variant increases pentamer stability, which blunts dynamic regulation of calcium, showing that the assembly state itself is a regulatory node.
phospholamban complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLN | Dilated cardiomyopathy and arrhythmia with age-related penetrance | PLN R14del knock-in cardiomyocyte model to test pentamer stability and calcium dynamics |
| SERCA1 | Calcium handling and three-way complex formation with PLN and small ankyrin 1 | Co-immunoprecipitation and knockout models to map the three-way complex |
| ANK1 | Membrane scaffolding in the phospholamban complex | ANK1 knockout or tagged knock-in to assess complex assembly |
| PRKAR1A | Heart failure and contractility regulation | PRKAR1A knockout or point-mutation models to test contractility |
| MIF | Phospholamban phosphorylation in cardiac muscle | MIF overexpression or knockout to measure PLN phosphorylation |
PLN p.Arg14del cardiomyopathy
The phospholamban p.Arg14del variant is associated with cardiomyopathy, and age-related penetrance of this condition has been described. The R14del variant increases phospholamban pentamer stability, blunting dynamic regulation of calcium, which provides a mechanistic link between the phospholamban complex and dilated cardiomyopathy.
Malignant ventricular arrhythmias
Epicardial adipose tissue has been linked to malignant ventricular arrhythmias in phospholamban p.(Arg14del) variant carriers. This connects the phospholamban complex to arrhythmia risk in genetically defined patient populations.
Heart failure and contractility regulation
cAMP-dependent protein kinase signaling, including the RIα subunit, is essential for regulating cardiac contractility and heart failure development. Because PLN is a main determinant of contraction and relaxation via calcium regulation, the phospholamban complex sits within this contractility and heart failure framework.
Cardiac hypertrophy
Thyroid hormone signaling is involved in cardiac hypertrophy. Hypertrophic remodeling involves changes in calcium handling and contractile gene expression, contexts in which the phospholamban complex and its regulation are relevant.
From phospholamban complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PLN alter SR calcium handling? | PLN knockout cardiomyocyte model |
| Does the R14del variant change pentamer stability? | PLN R14del point-mutation knock-in model |
| How does PLN interact with SERCA1 and small ankyrin 1? | Tagged knock-in of PLN, SERCA1, or ANK1 for complex isolation |
| Does increased PLN phosphorylation change contractility? | PLN phospho-mimetic or phospho-dead knock-in |
| Does MIF regulate PLN phosphorylation in vivo? | MIF overexpression or knockout cardiac model |
| Does PRKAR1A signaling modulate heart failure progression? | PRKAR1A knockout or point-mutation model |
How to Study the phospholamban complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Protein-protein interactions in the phospholamban complex | Detecting PLN-SERCA1-small ankyrin 1 three-way complex |
| Calcium imaging | Intracellular calcium dynamics | Comparing wild-type and R14del PLN cardiomyocytes |
| Contractility assay | Muscle contraction and relaxation | Assessing functional impact of PLN variants |
| Phospho-specific immunoblotting | PLN phosphorylation status | Testing MIF-induced PLN phosphorylation |
| Mass spectrometry | Protein identity and post-translational modifications | Mapping PLN phosphorylation sites |
| Transcriptomics | Gene expression changes | Profiling hypertrophy and heart failure models |
| Genotyping | PLN variant status | Identifying p.Arg14del carriers for penetrance studies |
| Histology | Tissue and cellular morphology | Assessing epicardial adipose tissue in variant carriers |
Biochemical complex isolation
The phospholamban complex can be studied by isolating SR membrane fractions and detecting PLN homopentamers, as well as three-way complexes with SERCA1 and small ankyrin 1. Co-immunoprecipitation and crosslinking approaches are useful for capturing the pentameric and interacting states.
Calcium imaging and contractility assays
Because the phospholamban complex regulates intracellular calcium and muscle contraction and relaxation, calcium imaging and contractility measurements in cardiomyocytes are direct functional readouts. These assays can compare wild-type and R14del PLN models to quantify changes in calcium dynamics.
Phosphorylation analysis
Phospholamban phosphorylation is dynamically regulated, and macrophage migration inhibitory factor induces phospholamban phosphorylation in cardiac muscle. Phospho-specific antibodies and mass spectrometry can quantify PLN phosphorylation states under different signaling conditions.
Genetic and transcriptomic profiling
Cardiac hypertrophy and heart failure contexts involve changes in gene expression, including thyroid hormone signaling and cAMP-dependent kinase pathways. Transcriptomic profiling of PLN variant models can reveal downstream changes linked to the phospholamban complex.
How CRISPR Can Be Used to Study GO:1990629 phospholamban complex
Knockout
CRISPR knockout of PLN can eliminate the phospholamban complex and reveal its contribution to SR calcium handling and contractility. Knockout of interacting partners such as ANK1 or SERCA1 can dissect the three-way complex.
Point Mutation
CRISPR point mutation can introduce the PLN R14del variant to model increased pentamer stability and blunted calcium regulation. Point mutations in PRKAR1A can also test contractility and heart failure pathways.
Knock-in
Knock-in of tagged PLN, SERCA1, or ANK1 enables affinity purification and imaging of the phospholamban complex. Knock-in of phospho-mimetic or phospho-dead PLN can test phosphorylation-dependent regulation.
Overexpression
Overexpression of MIF can test whether increased MIF signaling induces phospholamban phosphorylation in cardiac muscle. Overexpression of PLN variants can probe dosage effects on calcium handling and contractility.
How EDITGENE Supports phospholamban complex Research
Researchers studying phospholamban complex-related genes often need to determine whether a candidate gene is causally involved in calcium handling, contractility, or cardiomyopathy, and CRISPR-based models provide a direct way to test these hypotheses.
Contact EDITGENE today to design your custom CRISPR model for phospholamban complex research.
Frequently Asked Questions About phospholamban complex
What is the phospholamban complex?
The phospholamban complex (GO:1990629) is a homopentamer of the PLN protein in the sarcoplasmic reticulum membrane of cardiomyocytes that regulates intracellular calcium and muscle contraction and relaxation.
What genes are involved in the phospholamban complex?
Key genes include PLN, which forms the complex, and interacting partners such as SERCA1 and ANK1, along with signaling genes like MIF and PRKAR1A.
What does GO:1990629 mean?
GO:1990629 is the Gene Ontology cellular_component term for the phospholamban complex, defined as a PLN homopentamer in the cardiomyocyte SR membrane.
How does the phospholamban complex regulate calcium?
Cardiac PLN is a main determinant of muscle contraction and relaxation by regulating intracellular calcium levels, and its pentamer stability affects dynamic calcium regulation.
What diseases are linked to the phospholamban complex?
PLN p.Arg14del is linked to cardiomyopathy with age-related penetrance and to malignant ventricular arrhythmias in variant carriers.
Why is the PLN R14del variant important?
The R14del variant increases phospholamban pentamer stability and blunts dynamic regulation of calcium, providing a mechanism for dilated cardiomyopathy.
How is phospholamban phosphorylation regulated?
Macrophage migration inhibitory factor induces phospholamban phosphorylation in cardiac muscle, and cAMP-dependent kinase signaling regulates cardiac contractility.
What proteins interact with the phospholamban complex?
Small ankyrin 1 interacts with phospholamban and forms a three-way complex with SERCA1.
How can researchers study the phospholamban complex?
Methods include co-immunoprecipitation, calcium imaging, contractility assays, phosphorylation analysis, and transcriptomics.
What CRISPR models are used for phospholamban complex research?
Knockout, point-mutation, knock-in, and overexpression models of PLN and interacting genes are used to test calcium handling and contractility.
Conclusion
The phospholamban complex (GO:1990629) is a central regulator of cardiac calcium handling, built from a PLN homopentamer in the sarcoplasmic reticulum membrane of cardiomyocytes. Its assembly state and phosphorylation status control contraction and relaxation, and the R14del variant links it directly to cardiomyopathy and arrhythmia. Studying this complex with CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with biochemical and functional assays, offers a rigorous path to understanding inherited heart disease mechanisms.
References
- 1. Dillmann W. 2010. Cardiac hypertrophy and thyroid hormone signaling.. Heart Fail Rev 15(2):125-32 PMID: 19125327
- 2. Verstraelen TE et al.. 2025. Age-related penetrance of phospholamban p.Arg14del cardiomyopathy.. Eur J Heart Fail 27(12):3269-3277 PMID: 40264254
- 3. Mahmoud B et al.. 2025. Epicardial adipose tissue and malignant ventricular arrhythmias in phospholamban p.(Arg14del) variant carriers.. Eur Heart J 46(18):1766-1768 PMID: 40067768
- 4. Bedioune I et al.. 2024. Essential Role of the RIα Subunit of cAMP-Dependent Protein Kinase in Regulating Cardiac Contractility and Heart Failure Development.. Circulation 150(25):2031-2045 PMID: 39355927
- 5. Labuza A et al.. 2025. Small Ankyrin 1 Interacts with Phospholamban and Forms a Three-Way Complex with SERCA1.. Biochemistry 64(19):4055-4066 PMID: 40998301
- 6. Xiao F et al.. 2024. Adducin Regulates Sarcomere Disassembly During Cardiomyocyte Mitosis.. Circulation 150(10):791-805 PMID: 38708635
- 7. Tang Z et al.. 2025. Macrophage migration inhibitory factor induces phospholamban phosphorylation in cardiac muscle.. Cell Calcium 130:103051 PMID: 40680416
- 8. Cleary SR et al.. 2025. Dilated cardiomyopathy variant R14del increases phospholamban pentamer stability, blunting dynamic regulation of calcium.. J Biol Chem 301(2):108118 PMID: 39710323
